Sunday, May 22, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

Thailand Begins Coronavirus Vaccine Trials on Monkeys

by Global Biodefense Staff
May 23, 2020
Thailand Begins Coronavirus Vaccine Trials on Monkeys

Credit: Louis Reed / Unsplash

Thailand’s National Vaccine Institute (NVI) at Chulalongkorn University today began testing a trial vaccine against the novel coronavirus on non-human primates after positive trials in mice, said Taweesin Wisanuyothin, spokesman for the government’s Centre for COVID-19 Situation Administration.

The Thai vaccine uses messenger RNA (mRNA) which prompts body cells to produce antigens, molecules on the surface of viruses, that spur the immune system into action.1

NVI director Dr. Nakorn Premsri noted that if animal testing phase shows convincing results by stimulating the creation of antibodies, the vaccine will move to multi-phase human trials in progressively larger cohorts.2

The NVI is reportedly preparing to sign a Memorandum of Understanding (MoU) with Chinese partners to test a COVID-19 vaccine in Thailand. The Thai

government plans to include a technology transfer aspect to the agreement so that Thailand also can be a producer of the vaccines.3

READ MORE

1. Thailand begins coronavirus vaccine trials on monkeys Reuters

2. Thai National Vaccines Institute tests COVID-19 vaccine in animals XinhuaNet

3. A new direction for China biopharma Bangkok Post

Tags: Animal ModelsClinical TrialsCOVID-19Editor PickSARS-CoV-2Vaccines

Related Posts

Biodefense Headlines – 4 May 2022
News Scan

Biodefense Headlines – 4 May 2022

May 4, 2022
New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs
Medical Countermeasures

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

April 10, 2022
Yersinia pestis
Funding News

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

April 8, 2022
Troubling Trends in Physician Vaccine Confidence in the United States
Medical Countermeasures

Troubling Trends in Physician Vaccine Confidence in the United States

April 5, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC